Laboratory Testing Brings Clarity to Brucellosis - Top-Institutions - MDSpire

Laboratory Testing Brings Clarity to Brucellosis

Multimodal testing identifies Brucella abortus across cattle, goats, pigs, and sheep

  • February 5, 2026

  • 3 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    Centers for Disease Control and Prevention (CDC)
    Centers for Disease Control and Prevention (CDC)

    Atlanta, GA

    Key Differentiators

    • Infectious Diseases
    • Zoonotic Diseases
    • Epidemiology
    • Molecular Diagnostics

  • #2

    The Pirbright Institute
    The Pirbright Institute

    Woking, Surrey, UK

    Key Differentiators

    • Veterinary Infectious Diseases
    • Molecular Biology
    • Zoonoses

  • #3

    Institut Pasteur
    Institut Pasteur

    Paris, Île-de-France, France

    Key Differentiators

    • Microbiology
    • Infectious Diseases
    • Zoonoses
    • Molecular Epidemiology

  • #4

    University of California, Davis (UC Davis) School of Veterinary Medicine
    University of California, Davis (UC Davis) School of Veterinary Medicine

    Davis, CA

    Key Differentiators

    • Veterinary Medicine
    • Infectious Diseases
    • Zoonoses
    • Diagnostic Microbiology

  • #5

    International Livestock Research Institute (ILRI)
    International Livestock Research Institute (ILRI)

    Nairobi, Kenya

    Key Differentiators

    • Veterinary Epidemiology
    • Zoonotic Diseases
    • Livestock Health

Original Source(s)

Laboratory Testing Brings Clarity to Brucellosis

  • February 5, 2026

Related Content

Clinical characteristics and long-term prognosis of talaromycosis in children with novel and reported inborn errors of immunity

Commentary: Comment on "Comparative analysis of blood routine, C-reactive protein, and biochemical markers in children with Mycoplasma pneumoniae pneumonia and its coinfections"

Antibiotic Falls Short in Disc-Related Back Pain

A randomized trial found no greater pain reduction vs placebo, but questions remain about patients with type 1 Modic changes.